CD274 and non-small cell lung carcinoma: In a subgroup analysis of the EMPOWER Lung-01 study (50), elderly patients with advanced NSCLC and high PD-L1 expression experienced significant extensions in both OS and PFS when treated with cemiplimab compared to chemotherapy.